𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma

✍ Scribed by Jonathan Verma; Eric Jonasch; Pamela Allen; Nizar Tannir; Anita Mahajan

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
382 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The inhibitory effect of connexin 32 gen
The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma
✍ Hiromi Sato; Hiromi Hagiwara; Hironobu Senba; Keiko Fukumoto; Yoji Nagashima; Hi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 267 KB

## Abstract We have previously reported that connexin (Cx) 32 gene, a member of gap junctions, was specifically downregulated in human renal cell carcinoma (RCC) and it acts as a tumor suppressor against RCC. Because there is no standard therapy for advanced RCC, we investigated the anti‐metastatic

Targeted molecular therapy of head and n
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model
✍ Daisuke Sano; David R. Fooshee; Mei Zhao; Genevieve A. Andrews; Mitchell J. Fred πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 2 views

## Abstract ## Background We investigated the effects of vandetanib, an inhibitor of vascular endothelial growth factor receptor 2 (VEGFR‐2) and epidermal growth factor receptor (EGFR), alone and in combination with paclitaxel in an orthotopic mouse model of human head and neck squamous cell carci

Effects of tyrosine kinase inhibitors on
Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway
✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr

A population-based study evaluating the
A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer
✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH